Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Titel:
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Auteur:
Mahadevan, Daruka Sutton, Gregory Ryan Arteta-Bulos, Rafael Bowden, Chris J. Miller, Paul J. E. Swart, Rachel Elizabeth Walker, Mark S. Haluska, Paul Munster, Pamela N. Marshall, John Hamid, Omid Kurzrock, Razelle